Steigerwald Gordon & Koch’s Biogen BIIB Stock Holding History

Steigerwald Gordon & Koch’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.5K	Hold	81	–	–	﹤0.01%	459
2026 Q1	$14.8K	Buy	81 +2	+3%	+$369	﹤0.01%	472
2025 Q4	$13.9K	Hold	79	–	–	﹤0.01%	512
2025 Q3	$11.1K	Buy	+79	New	+$10.7K	﹤0.01%	515

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steigerwald Gordon & Koch's BIIB Position: Q2 2026 in Review

Steigerwald Gordon & Koch held its Biogen (BIIB) position steady in Q2 2026 at 81 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #459.

Steigerwald Gordon & Koch first reported a position in BIIB in Q3 2025 and has held it in 4 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Steigerwald Gordon & Koch held 81 shares of Biogen worth $17.5K as of Q2 2026.
Steigerwald Gordon & Koch left its Biogen share count unchanged in Q2 2026.
Biogen made up ﹤0.01% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #459 holding.
Steigerwald Gordon & Koch first reported a position in Biogen in Q3 2025 and has held it in 4 quarters since.
1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.